MLAB — MESA LABORATORIES INC /CO/

—
Nasdaq · Unknown · Unknown · CIK 724004 ·
Last close
$134.60
Market Cap
$756.52M
52W High
$144.35
52W Low
$69.06
ADV30
103,360
Next earnings
2027-02-03
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 62,336,000 39,878,000 8,388,000 4,341,000 407,735,000 22,312,000 213,139,000
Jun 2026 60,138,000 39,012,000 7,031,000 2,830,000 419,224,000 30,695,000 230,464,000
Mar 2026 63,724,000 42,205,000 2,748,000 -4,136,000 427,747,000 26,928,000 241,502,000
Dec 2025 65,126,000 41,795,000 7,975,000 3,630,000 434,849,000 28,975,000 248,158,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$51,548,000
Investing CF
$-2,095,000
Financing CF
$-48,356,000
CapEx
$-2,095,000
Dividends Paid
$-3,550,000
Buybacks
—
EPS Diluted TTM
$1.14
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-180,358,000
Inventory
$26,550,000
Receivables
$39,384,000
ST Investments
—
EBIT TTM
$23,522,000
Pretax Income TTM
$13,390,000
Interest Exp TTM
$10,132,000
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$251,324,000
EBITDA
$48,813,000
Free Cash Flow
$51,598,248
Enterprise Value
$906,863,488
Total Cash
$23,948,000
Total Debt
$149,503,008
Shares Out
5,620,520
Trailing EPS
$1.16
Book Value
$34.66
ROE
3.6%
ROA
3.9%
Div Yield
0.46%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Mar 2026 249,130,000 18,511,000 6,712,000 427,747,000 241,502,000 186,245,000 42,831,000
Mar 2025 240,978,000 16,336,000 -1,974,000 433,348,000 273,518,000 159,830,000 46,808,000
Mar 2024 216,187,000 2,458,000 -254,246,000 446,796,000 301,403,000 145,393,000 44,133,000
Mar 2023 219,080,000 3,320,000 930,000 661,832,000 268,352,000 393,480,000 27,983,000

TTM Snapshot

Revenues TTM
$249,725,000
NetIncome TTM
$4,800,000
OpCashFlow TTM
—
Assets (Latest)
$419,224,000
Forward EPS
$12.17

Peers — same industry

TickerNameMarket CapLastDaily %
FDUS FIDUS INVESTMENT Corp $756.04M $19.01 —
PXED Phoenix Education Partners, Inc. $754.07M $20.56 —
PSEC PROSPECT CAPITAL CORP $751.94M $1.35 —
LGSXY Light S.A./ADR $765.07M $0.95 —
GGN GAMCO Global Gold, Natural Resources & Income Trust $765.50M $4.90 —

News headlines (Yahoo Finance, 1h cache)

Sterilization Monitoring Technologies - Global Strategic Business Report 2026: Secure Share of the $1 Billion Market by 2032 | Features Competitive Intelligence on 3M, Steris, Getinge, Cardinal Health
2026-11-12 14:55 · Yahoo
Mesa Laboratories Inc (MLAB) Q2 2027 Earnings Call Highlights: Margin Expansion and ...
2026-11-10 09:07 · Yahoo
Mesa Laboratories, Inc. Q2 2027 Earnings Call Summary
2026-11-10 03:03 · Yahoo
Mesa Labs (MLAB) Q2 2027 Earnings Call Transcript
2026-11-10 02:45 · Yahoo
What Mesa Laboratories (MLAB) Said on Its Q2 Earnings Call
2026-11-10 00:14 · Yahoo
Mesa Labs: Fiscal Q2 Earnings Snapshot
2026-11-09 23:03 · Yahoo
Mesa Labs Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year Guidance
2026-11-09 21:40 · Yahoo
Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call
2026-10-28 20:00 · Yahoo
Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth
2026-10-13 12:00 · Yahoo
MESA LABS DECLARES QUARTERLY DIVIDEND
2026-10-09 20:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.